<DOC>
	<DOCNO>NCT00467376</DOCNO>
	<brief_summary>Primary : - To compare efficacy safety Insulin Glulisine Insulin Lispro subject type 1 type 2 diabetes mellitus . - To compare frequency hypoglycemia Insulin Glulisine Insulin Lispro . Secondary : - To compare Insulin Glulisine Insulin Lispro term change HbA1c week 12 , blood glucose parameter , insulin dos treatment satisfaction subject type 1 type 2 diabetes mellitus</brief_summary>
	<brief_title>Insulin Glulisine , Insulin Lispro Insulin Glargine Type 1 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 1 type 2 diabetic patient Measure HbA1c 6.5 % 11.0 % visit 1 More 3 month continuous insulin treatment immediately prior study entry Pregnant woman The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>